Fluoride: Page 58

Patch more effective than mouthwash on xerostomia
By DrBicuspid.com staff writers
A new time-released, muco-adhesive patch for treating xerostomia and other oral health conditions has been shown to be more effective than a leading oral rinse, according to a new study.
March 21, 2010
Wash. hopes tamper-resistant paper will curb prescription fraud
By DrBicuspid.com staff writers
To curb prescription fraud and abuse, the state of Washington will require all prescriptions to be printed on tamper-resistant paper with ink that changes color when rubbed with a finger starting July 1.
March 4, 2010
Novalar partners with Sanofi to sell OraVerse in Europe
By DrBicuspid.com staff writers
Novalar Pharmaceuticals has entered into an exclusive license and distribution agreement with Sanofi-Aventis Deutschland to offer its vasodilator drug phentolamine mesylate, OraVerse, in Germany beginning in 2011, the companies announced.
March 2, 2010
FDA rejects OraVerse brochure
By DrBicuspid.com staff writers
The U.S. FDA has asked Novalar Pharmaceuticals to stop distributing a patient brochure for the drug OraVerse (phentolamine mesylate), which it markets for reversing the effects of local anesthesia.
February 25, 2010
Judge refuses to dismiss Fosamax case, sets trial
By Reuters Health
NEW YORK (Reuters), Jan 29 - A Manhattan federal judge refused on Friday to dismiss a lawsuit alleging that Merck & Co. Inc.'s osteoporosis drug Fosamax caused jaw damage to an Indiana woman during the nearly eight years she took the pill.
January 28, 2010
2007 07 16 11 33 13 706
Rituximab effective for Sjögren's syndrome
By Reuters Health
NEW YORK (Reuters Health), Jan 26 - Rituximab can improve saliva secretion and other parameters in patients with primary Sjögren's syndrome, researchers report.
January 25, 2010
2007 07 16 11 33 13 706
Oragenics offers probiotic chew for kids
By DrBicuspid.com staff writers
Oragenics has launched EvoraKids, the first probiotic-based, all-natural oral care chewable created to promote oral health for children 3-10 years old. EvoraKids includes Oragenics' patent-pending ProBiora3 technology, specifically formulated for children to help maintain healthy teeth.
January 24, 2010
Black raspberries fuel new oral cancer drug
By DrBicuspid.com staff writers
Regulatory Affairs Associates (RAA) has signed a contract with Ohio State University to manufacture clinical supplies for a new drug designed to prevent oral cancer. The topical gel formulation uses anthocyanins obtained from black raspberries as the active component. Anthocyanins are promising cancer-preventing agents due to their antioxidant and anti-inflammatory properties.
January 19, 2010
NH dentists want MDs' help
By DrBicuspid.com staff writers
Pediatricians should offer more dental services and communities should fluoridate their water, the New Hampshire Dental Society is arguing in a new report, according to the Boston Globe.
January 18, 2010
Treatment approaches for patients at risk of osteonecrosis
By Rabia Mughal
Bisphosphonate-related osteonecrosis of the jaw is a relatively new condition triggered by increased use of bisphosphonate-based drugs. What do dental professionals need to know when dealing with patients at risk of this condition?
September 27, 2009
2009 06 04 14 09 47 485 Drb How To Bug
Lawsuit blames fentanyl lollipops for tooth decay
By DrBicuspid.com staff writers
A Texas man is suing Cephalon, alleging that the company's Actiq fentanyl lollipops -- prescribed as a painkiller for cancer patients -- rotted his teeth.
September 16, 2009
Time to rethink antimicrobials?
By Rochelle Sharpe
BOSTON - Despite concerns of antibiotic overuse and superresistant biofilms, systemic disease experts speaking at the American Academy of Periodontology meeting this week said that dentists should not be so reluctant to prescribe antibiotics for patients with severe gum disease.
September 16, 2009
2009 01 29 16 57 06 752 Boston 70
Previous Page
Page 58 of 62
Next Page